{"id":50762,"date":"2022-11-11T14:02:53","date_gmt":"2022-11-11T13:02:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/"},"modified":"2022-11-11T14:02:53","modified_gmt":"2022-11-11T13:02:53","slug":"rallybio-to-present-at-upcoming-investor-conferences-in-november","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/","title":{"rendered":"Rallybio to Present at Upcoming Investor Conferences in November"},"content":{"rendered":"<div>\n<p>NEW HAVEN, Conn.&#8211;(BUSINESS WIRE)&#8211;Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221109006005\/en\/1407047\/5\/Press_Release_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221109006005\/en\/1407047\/21\/Press_Release_Logo.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Jefferies London Healthcare Conference<\/b> in London, United Kingdom on Tuesday, November 15, 2022, at 8:35 a.m. GMT (3:35 a.m. EST)\n<\/li>\n<li>\n<b>Evercore ISI 5th Annual HealthCONx Conference <\/b>being held virtually on Wednesday, November 30, 2022, at 8:25 a.m. EST.\n<\/li>\n<\/ul>\n<p>\nLive webcasts of both fireside chats will be accessible through the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.rallybio.com%2Fevents-and-presentations%2Fevents&amp;esheet=52965716&amp;newsitemid=20221109006005&amp;lan=en-US&amp;anchor=Events+and+Presentations&amp;index=1&amp;md5=315e0c3f76e15ccbc16eee4d18536001\" rel=\"nofollow noopener\" shape=\"rect\">Events and Presentations<\/a> section of Rallybio\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rallybio.com&amp;esheet=52965716&amp;newsitemid=20221109006005&amp;lan=en-US&amp;anchor=www.rallybio.com&amp;index=2&amp;md5=d467e4cfca2beba717e9c67c8aba9221\" rel=\"nofollow noopener\" shape=\"rect\">www.rallybio.com<\/a>. A replay of the webcasts will be available for 30 days following each event.\n<\/p>\n<p>\n<b>About Rallybio<\/b>\n<\/p>\n<p>\nRallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology, immuno-inflammation, maternal fetal health, and metabolic disorders. The Company\u2019s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. Rallybio is headquartered in New Haven, Connecticut, with an additional facility at the University of Connecticut\u2019s Technology Incubation Program in Farmington, Connecticut. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rallybio.com&amp;esheet=52965716&amp;newsitemid=20221109006005&amp;lan=en-US&amp;anchor=www.rallybio.com&amp;index=3&amp;md5=9ba5d2e344bfb7754ec90ff11f50ca47\" rel=\"nofollow noopener\" shape=\"rect\">www.rallybio.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investors<\/b><br \/>Ami Bavishi<br \/>\n<br \/>Head of Investor Relations and Corporate Communications<br \/>\n<br \/>609-477-4536<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;t&#111;&#x3a;&#97;&#x62;a&#118;&#x69;&#115;&#x68;i&#x40;&#x72;&#97;&#x6c;l&#x79;b&#105;&#x6f;&#46;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x61;&#x62;&#97;&#118;i&#x73;&#x68;&#x69;&#64;ra&#x6c;&#x6c;&#121;&#98;i&#x6f;&#x2e;&#x63;&#111;m<\/a>\n<\/p>\n<p>\nHannah Deresiewicz<br \/>\n<br \/>Stern Investor Relations, Inc.<br \/>\n<br \/>212-362-1200<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x68;&#97;&#x6e;&#110;&#x61;h&#x2e;d&#x65;r&#x65;s&#x69;e&#x77;i&#99;&#x7a;&#64;&#x73;&#116;&#x65;&#114;&#x6e;&#105;&#x72;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x68;a&#x6e;&#110;&#x61;&#x68;&#46;&#x64;&#101;&#x72;&#x65;s&#x69;&#101;&#x77;&#x69;c&#x7a;&#64;&#x73;&#x74;e&#x72;&#110;&#x69;&#x72;&#46;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Media<\/b><br \/>Tara DiMilia<br \/>\n<br \/>908-369-7168<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;&#108;&#x74;&#x6f;:&#x54;&#x61;r&#97;&#x2e;d&#105;&#x6d;i&#108;&#x69;a&#64;&#x74;m&#115;&#x74;&#x72;&#97;&#x74;&#x2e;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#84;&#x61;&#114;&#x61;&#46;&#100;&#x69;&#109;&#x69;l&#x69;a&#64;&#x74;&#109;&#x73;t&#x72;&#x61;&#116;&#x2e;c&#x6f;m<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn.&#8211;(BUSINESS WIRE)&#8211;Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies London Healthcare Conference in London, United Kingdom on Tuesday, November 15, 2022, at 8:35 a.m. GMT &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50762","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rallybio to Present at Upcoming Investor Conferences in November - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rallybio to Present at Upcoming Investor Conferences in November - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn.&#8211;(BUSINESS WIRE)&#8211;Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies London Healthcare Conference in London, United Kingdom on Tuesday, November 15, 2022, at 8:35 a.m. GMT ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-11T13:02:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221109006005\/en\/1407047\/21\/Press_Release_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Rallybio to Present at Upcoming Investor Conferences in November\",\"datePublished\":\"2022-11-11T13:02:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/\"},\"wordCount\":272,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221109006005\\\/en\\\/1407047\\\/21\\\/Press_Release_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/\",\"name\":\"Rallybio to Present at Upcoming Investor Conferences in November - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221109006005\\\/en\\\/1407047\\\/21\\\/Press_Release_Logo.jpg\",\"datePublished\":\"2022-11-11T13:02:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221109006005\\\/en\\\/1407047\\\/21\\\/Press_Release_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221109006005\\\/en\\\/1407047\\\/21\\\/Press_Release_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rallybio-to-present-at-upcoming-investor-conferences-in-november\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rallybio to Present at Upcoming Investor Conferences in November\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rallybio to Present at Upcoming Investor Conferences in November - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/","og_locale":"en_US","og_type":"article","og_title":"Rallybio to Present at Upcoming Investor Conferences in November - Pharma Trend","og_description":"NEW HAVEN, Conn.&#8211;(BUSINESS WIRE)&#8211;Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies London Healthcare Conference in London, United Kingdom on Tuesday, November 15, 2022, at 8:35 a.m. GMT ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-11T13:02:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221109006005\/en\/1407047\/21\/Press_Release_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Rallybio to Present at Upcoming Investor Conferences in November","datePublished":"2022-11-11T13:02:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/"},"wordCount":272,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221109006005\/en\/1407047\/21\/Press_Release_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/","url":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/","name":"Rallybio to Present at Upcoming Investor Conferences in November - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221109006005\/en\/1407047\/21\/Press_Release_Logo.jpg","datePublished":"2022-11-11T13:02:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221109006005\/en\/1407047\/21\/Press_Release_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221109006005\/en\/1407047\/21\/Press_Release_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rallybio-to-present-at-upcoming-investor-conferences-in-november\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Rallybio to Present at Upcoming Investor Conferences in November"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50762"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50762\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}